Archan Ruparel

Archan Ruparel | Economist Expert Life Sciences | Charles River Associates

Mr. Ruparel advises clients on the economics of the life sciences industry. He has served as an expert witness and non-testifying expert on issues including antitrust liability, class certification, and damages.

Archan regularly provides economic expertise in disputes, including antitrust matters, intellectual property litigation, and commercial disputes. He has advised pharmaceutical companies, pharmacy benefits managers, insurers, and regulators. He has presented before federal and state regulators and provided analysis in disputes before regulatory boards, judges, arbitration panels, and juries. Mr. Ruparel has also assisted life sciences companies and counsel on complex questions involving development, pricing and market access, loss of exclusivity, and follow-on products.

Prior to joining CRA, Mr. Ruparel served in the Bureau of Economics of the Federal Trade Commission. At the FTC, Mr. Ruparel conducted a study of credit-based insurance scores and pharmaceutical direct-to-consumer advertising as well as investigations and litigation involving hospital mergers, telemarketing, and fair lending.

Mr. Ruparel serves on CRA’s pro bono committee.

Selected Engagements

  • 01
    Assessment of irreparable harm for an osteoporosis treatment
    Following a district court finding of invalidity and/or non-infringement and plaintiff’s stated intention to appeal, CRA was asked to assess whether branded...
    View engagement
  • 02
    Evaluation of alleged manipulation of industry drug standard setting
    In a matter involving alleged abuse of the U.S. Pharmacopeia standard setting process, CRA examined market power for product dispensed through hospital and...
    View engagement
  • 03
    Evaluation of extended-release pain medication
    CRA consultants supported Plaintiff in a patent litigation regarding an extended-release formulation of an anti-pain medication. CRA assessed the commercial...
    View engagement